Watspas 80mg/250mg Tablet
Marketer
Watran Pharmaceuticals Pvt. Ltd.
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Watspas 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Relpax 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing the gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Relpax 80mg/250mg Tablets should be taken with food, following your physician's prescribed dosage and duration. Your individual dosage will be determined by your condition and response to treatment. Continue taking this medication as directed by your doctor; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach pain, dry mouth, anorexia, thirst, and heartburn; most are transient and self-limiting. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential exacerbation of dizziness. Consult your physician before taking this medicine if you are pregnant, planning pregnancy, breastfeeding, or have kidney or liver impairment to ensure appropriate dosage.
Primary Ingredients of Watspas 80mg/250mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Watspas 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Watspas 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Watspas 80mg/250mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Watspas 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Watspas 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Watspas 80mg/250mg Tablet should be administered with a meal.
How Watspas 80mg/250mg Tablet works:
Each Watspas 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal muscle spasms. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-causing substances within the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Watspas 80mg/250mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Watspas 80mg/250mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Watspas 80mg/250mg tablets while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
The medication Watspas 80mg/250mg Tablet may induce adverse reactions, potentially impairing driving ability due to the possibility of dizziness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Watspas 80mg/250mg tablets; dosage modification may be necessary. Consult a physician. Watspas 80mg/250mg tablets are contraindicated in patients with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should use the 80mg/250mg Watspas Tablet cautiously. Dosage modification of the 80mg/250mg Watspas Tablet may be necessary. Physician consultation is advised.
What if you forget to take Watspas 80mg/250mg Tablet :
Should you forget a Watspas 80mg/250mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Watspas 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently